▶ 調査レポート

世界の前臨床CRO市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Preclinical CRO Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の前臨床CRO市場規模・現状・予測(2021年-2027年) / Global Preclinical CRO Market Size, Status and Forecast 2021-2027 / QFJ1-4746資料のイメージです。• レポートコード:QFJ1-4746
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、前臨床CROの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(セキュリティ評価サービス、薬物動態研究、薬力研究、その他)、用途別市場規模(製薬産業、バイオテクノロジー)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・前臨床CROの市場動向
・企業の競争状況、市場シェア
・前臨床CROの種類別市場規模と予測2016-2027(セキュリティ評価サービス、薬物動態研究、薬力研究、その他)
・前臨床CROの用途別市場規模と予測2016-2027(製薬産業、バイオテクノロジー)
・前臨床CROの北米市場規模2016-2027(アメリカ、カナダ)
・前臨床CROの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・前臨床CROのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・前臨床CROの中南米市場規模2016-2027(メキシコ、ブラジル)
・前臨床CROの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Charles River、Eurofins Scientific、Wuxi AppTec、Pharmaceutical Product Development (PPD), LLC、ICON Plc.、Labcorp、CRL、Crown Bioscience、Taconic Biosciences、Covance、EVOTEC、The Jackson Laboratory、MI Bioresearch、Champion Oncology、Xentech、Living Tumor Laboratory、JOINN Lab)
・結論

Market Analysis and Insights: Global Preclinical CRO Market
The global Preclinical CRO market size is projected to reach US$ 4880.9 million by 2027, from US$ 3452.8 million in 2020, at a CAGR of 4.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO market.

Global Preclinical CRO Scope and Market Size
Preclinical CRO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Security Evaluation Service
Pharmacokinetic Research
Pharmacodynamic Research
Other

Segment by Application
Pharmaceutical Industry
Biotechnology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Charles River
Eurofins Scientific
Wuxi AppTec
Pharmaceutical Product Development (PPD), LLC
ICON Plc.
Labcorp
CRL
Crown Bioscience
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Xentech
Living Tumor Laboratory
JOINN Lab

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Security Evaluation Service
1.2.3 Pharmacokinetic Research
1.2.4 Pharmacodynamic Research
1.2.5 Other
1.3 Market by Application
1.3.1 Global Preclinical CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preclinical CRO Market Perspective (2016-2027)
2.2 Preclinical CRO Growth Trends by Regions
2.2.1 Preclinical CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical CRO Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical CRO Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical CRO Industry Dynamic
2.3.1 Preclinical CRO Market Trends
2.3.2 Preclinical CRO Market Drivers
2.3.3 Preclinical CRO Market Challenges
2.3.4 Preclinical CRO Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Players by Revenue
3.1.1 Global Top Preclinical CRO Players by Revenue (2016-2021)
3.1.2 Global Preclinical CRO Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical CRO Revenue
3.4 Global Preclinical CRO Market Concentration Ratio
3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2020
3.5 Preclinical CRO Key Players Head office and Area Served
3.6 Key Players Preclinical CRO Product Solution and Service
3.7 Date of Enter into Preclinical CRO Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Breakdown Data by Type
4.1 Global Preclinical CRO Historic Market Size by Type (2016-2021)
4.2 Global Preclinical CRO Forecasted Market Size by Type (2022-2027)

5 Preclinical CRO Breakdown Data by Application
5.1 Global Preclinical CRO Historic Market Size by Application (2016-2021)
5.2 Global Preclinical CRO Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preclinical CRO Market Size (2016-2027)
6.2 North America Preclinical CRO Market Size by Type
6.2.1 North America Preclinical CRO Market Size by Type (2016-2021)
6.2.2 North America Preclinical CRO Market Size by Type (2022-2027)
6.2.3 North America Preclinical CRO Market Size by Type (2016-2027)
6.3 North America Preclinical CRO Market Size by Application
6.3.1 North America Preclinical CRO Market Size by Application (2016-2021)
6.3.2 North America Preclinical CRO Market Size by Application (2022-2027)
6.3.3 North America Preclinical CRO Market Size by Application (2016-2027)
6.4 North America Preclinical CRO Market Size by Country
6.4.1 North America Preclinical CRO Market Size by Country (2016-2021)
6.4.2 North America Preclinical CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Preclinical CRO Market Size (2016-2027)
7.2 Europe Preclinical CRO Market Size by Type
7.2.1 Europe Preclinical CRO Market Size by Type (2016-2021)
7.2.2 Europe Preclinical CRO Market Size by Type (2022-2027)
7.2.3 Europe Preclinical CRO Market Size by Type (2016-2027)
7.3 Europe Preclinical CRO Market Size by Application
7.3.1 Europe Preclinical CRO Market Size by Application (2016-2021)
7.3.2 Europe Preclinical CRO Market Size by Application (2022-2027)
7.3.3 Europe Preclinical CRO Market Size by Application (2016-2027)
7.4 Europe Preclinical CRO Market Size by Country
7.4.1 Europe Preclinical CRO Market Size by Country (2016-2021)
7.4.2 Europe Preclinical CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Market Size (2016-2027)
8.2 Asia-Pacific Preclinical CRO Market Size by Type
8.2.1 Asia-Pacific Preclinical CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical CRO Market Size by Application
8.3.1 Asia-Pacific Preclinical CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical CRO Market Size by Region
8.4.1 Asia-Pacific Preclinical CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preclinical CRO Market Size (2016-2027)
9.2 Latin America Preclinical CRO Market Size by Type
9.2.1 Latin America Preclinical CRO Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical CRO Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical CRO Market Size by Type (2016-2027)
9.3 Latin America Preclinical CRO Market Size by Application
9.3.1 Latin America Preclinical CRO Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical CRO Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical CRO Market Size by Application (2016-2027)
9.4 Latin America Preclinical CRO Market Size by Country
9.4.1 Latin America Preclinical CRO Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Market Size (2016-2027)
10.2 Middle East & Africa Preclinical CRO Market Size by Type
10.2.1 Middle East & Africa Preclinical CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical CRO Market Size by Application
10.3.1 Middle East & Africa Preclinical CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical CRO Market Size by Country
10.4.1 Middle East & Africa Preclinical CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Preclinical CRO Introduction
11.1.4 Charles River Revenue in Preclinical CRO Business (2016-2021)
11.1.5 Charles River Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Preclinical CRO Introduction
11.2.4 Eurofins Scientific Revenue in Preclinical CRO Business (2016-2021)
11.2.5 Eurofins Scientific Recent Development
11.3 Wuxi AppTec
11.3.1 Wuxi AppTec Company Details
11.3.2 Wuxi AppTec Business Overview
11.3.3 Wuxi AppTec Preclinical CRO Introduction
11.3.4 Wuxi AppTec Revenue in Preclinical CRO Business (2016-2021)
11.3.5 Wuxi AppTec Recent Development
11.4 Pharmaceutical Product Development (PPD), LLC
11.4.1 Pharmaceutical Product Development (PPD), LLC Company Details
11.4.2 Pharmaceutical Product Development (PPD), LLC Business Overview
11.4.3 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Introduction
11.4.4 Pharmaceutical Product Development (PPD), LLC Revenue in Preclinical CRO Business (2016-2021)
11.4.5 Pharmaceutical Product Development (PPD), LLC Recent Development
11.5 ICON Plc.
11.5.1 ICON Plc. Company Details
11.5.2 ICON Plc. Business Overview
11.5.3 ICON Plc. Preclinical CRO Introduction
11.5.4 ICON Plc. Revenue in Preclinical CRO Business (2016-2021)
11.5.5 ICON Plc. Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Details
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Preclinical CRO Introduction
11.6.4 Labcorp Revenue in Preclinical CRO Business (2016-2021)
11.6.5 Labcorp Recent Development
11.7 CRL
11.7.1 CRL Company Details
11.7.2 CRL Business Overview
11.7.3 CRL Preclinical CRO Introduction
11.7.4 CRL Revenue in Preclinical CRO Business (2016-2021)
11.7.5 CRL Recent Development
11.8 Crown Bioscience
11.8.1 Crown Bioscience Company Details
11.8.2 Crown Bioscience Business Overview
11.8.3 Crown Bioscience Preclinical CRO Introduction
11.8.4 Crown Bioscience Revenue in Preclinical CRO Business (2016-2021)
11.8.5 Crown Bioscience Recent Development
11.9 Taconic Biosciences
11.9.1 Taconic Biosciences Company Details
11.9.2 Taconic Biosciences Business Overview
11.9.3 Taconic Biosciences Preclinical CRO Introduction
11.9.4 Taconic Biosciences Revenue in Preclinical CRO Business (2016-2021)
11.9.5 Taconic Biosciences Recent Development
11.10 Covance
11.10.1 Covance Company Details
11.10.2 Covance Business Overview
11.10.3 Covance Preclinical CRO Introduction
11.10.4 Covance Revenue in Preclinical CRO Business (2016-2021)
11.10.5 Covance Recent Development
11.11 EVOTEC
11.11.1 EVOTEC Company Details
11.11.2 EVOTEC Business Overview
11.11.3 EVOTEC Preclinical CRO Introduction
11.11.4 EVOTEC Revenue in Preclinical CRO Business (2016-2021)
11.11.5 EVOTEC Recent Development
11.12 The Jackson Laboratory
11.12.1 The Jackson Laboratory Company Details
11.12.2 The Jackson Laboratory Business Overview
11.12.3 The Jackson Laboratory Preclinical CRO Introduction
11.12.4 The Jackson Laboratory Revenue in Preclinical CRO Business (2016-2021)
11.12.5 The Jackson Laboratory Recent Development
11.13 MI Bioresearch
11.13.1 MI Bioresearch Company Details
11.13.2 MI Bioresearch Business Overview
11.13.3 MI Bioresearch Preclinical CRO Introduction
11.13.4 MI Bioresearch Revenue in Preclinical CRO Business (2016-2021)
11.13.5 MI Bioresearch Recent Development
11.14 Champion Oncology
11.14.1 Champion Oncology Company Details
11.14.2 Champion Oncology Business Overview
11.14.3 Champion Oncology Preclinical CRO Introduction
11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2016-2021)
11.14.5 Champion Oncology Recent Development
11.15 Xentech
11.15.1 Xentech Company Details
11.15.2 Xentech Business Overview
11.15.3 Xentech Preclinical CRO Introduction
11.15.4 Xentech Revenue in Preclinical CRO Business (2016-2021)
11.15.5 Xentech Recent Development
11.16 Living Tumor Laboratory
11.16.1 Living Tumor Laboratory Company Details
11.16.2 Living Tumor Laboratory Business Overview
11.16.3 Living Tumor Laboratory Preclinical CRO Introduction
11.16.4 Living Tumor Laboratory Revenue in Preclinical CRO Business (2016-2021)
11.16.5 Living Tumor Laboratory Recent Development
11.17 JOINN Lab
11.17.1 JOINN Lab Company Details
11.17.2 JOINN Lab Business Overview
11.17.3 JOINN Lab Preclinical CRO Introduction
11.17.4 JOINN Lab Revenue in Preclinical CRO Business (2016-2021)
11.17.5 JOINN Lab Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preclinical CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Security Evaluation Service
Table 3. Key Players of Pharmacokinetic Research
Table 4. Key Players of Pharmacodynamic Research
Table 5. Key Players of Other
Table 6. Global Preclinical CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Preclinical CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Preclinical CRO Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Preclinical CRO Market Share by Regions (2016-2021)
Table 10. Global Preclinical CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Preclinical CRO Market Share by Regions (2022-2027)
Table 12. Preclinical CRO Market Trends
Table 13. Preclinical CRO Market Drivers
Table 14. Preclinical CRO Market Challenges
Table 15. Preclinical CRO Market Restraints
Table 16. Global Preclinical CRO Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Preclinical CRO Market Share by Players (2016-2021)
Table 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO as of 2020)
Table 19. Ranking of Global Top Preclinical CRO Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Preclinical CRO Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Preclinical CRO Product Solution and Service
Table 23. Date of Enter into Preclinical CRO Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Preclinical CRO Revenue Market Share by Type (2016-2021)
Table 27. Global Preclinical CRO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Preclinical CRO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Preclinical CRO Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Preclinical CRO Revenue Market Share by Application (2016-2021)
Table 31. Global Preclinical CRO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Preclinical CRO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Preclinical CRO Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Preclinical CRO Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Preclinical CRO Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Preclinical CRO Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Preclinical CRO Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Preclinical CRO Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Preclinical CRO Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Preclinical CRO Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Preclinical CRO Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Preclinical CRO Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Preclinical CRO Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preclinical CRO Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Preclinical CRO Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Preclinical CRO Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Preclinical CRO Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Preclinical CRO Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Preclinical CRO Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Preclinical CRO Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Preclinical CRO Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Preclinical CRO Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Preclinical CRO Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Preclinical CRO Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preclinical CRO Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Preclinical CRO Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Preclinical CRO Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Preclinical CRO Market Size by Country (2022-2027) & (US$ Million)
Table 63. Charles River Company Details
Table 64. Charles River Business Overview
Table 65. Charles River Preclinical CRO Product
Table 66. Charles River Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 67. Charles River Recent Development
Table 68. Eurofins Scientific Company Details
Table 69. Eurofins Scientific Business Overview
Table 70. Eurofins Scientific Preclinical CRO Product
Table 71. Eurofins Scientific Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 72. Eurofins Scientific Recent Development
Table 73. Wuxi AppTec Company Details
Table 74. Wuxi AppTec Business Overview
Table 75. Wuxi AppTec Preclinical CRO Product
Table 76. Wuxi AppTec Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 77. Wuxi AppTec Recent Development
Table 78. Pharmaceutical Product Development (PPD), LLC Company Details
Table 79. Pharmaceutical Product Development (PPD), LLC Business Overview
Table 80. Pharmaceutical Product Development (PPD), LLC Preclinical CRO Product
Table 81. Pharmaceutical Product Development (PPD), LLC Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 82. Pharmaceutical Product Development (PPD), LLC Recent Development
Table 83. ICON Plc. Company Details
Table 84. ICON Plc. Business Overview
Table 85. ICON Plc. Preclinical CRO Product
Table 86. ICON Plc. Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 87. ICON Plc. Recent Development
Table 88. Labcorp Company Details
Table 89. Labcorp Business Overview
Table 90. Labcorp Preclinical CRO Product
Table 91. Labcorp Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 92. Labcorp Recent Development
Table 93. CRL Company Details
Table 94. CRL Business Overview
Table 95. CRL Preclinical CRO Product
Table 96. CRL Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 97. CRL Recent Development
Table 98. Crown Bioscience Company Details
Table 99. Crown Bioscience Business Overview
Table 100. Crown Bioscience Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 101. Crown Bioscience Recent Development
Table 102. Taconic Biosciences Company Details
Table 103. Taconic Biosciences Business Overview
Table 104. Taconic Biosciences Preclinical CRO Product
Table 105. Taconic Biosciences Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 106. Taconic Biosciences Recent Development
Table 107. Covance Company Details
Table 108. Covance Business Overview
Table 109. Covance Preclinical CRO Product
Table 110. Covance Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 111. Covance Recent Development
Table 112. EVOTEC Company Details
Table 113. EVOTEC Business Overview
Table 114. EVOTEC Preclinical CRO Product
Table 115. EVOTEC Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 116. EVOTEC Recent Development
Table 117. The Jackson Laboratory Company Details
Table 118. The Jackson Laboratory Business Overview
Table 119. The Jackson Laboratory Preclinical CRO Product
Table 120. The Jackson Laboratory Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 121. The Jackson Laboratory Recent Development
Table 122. MI Bioresearch Company Details
Table 123. MI Bioresearch Business Overview
Table 124. MI Bioresearch Preclinical CRO Product
Table 125. MI Bioresearch Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 126. MI Bioresearch Recent Development
Table 127. Champion Oncology Company Details
Table 128. Champion Oncology Business Overview
Table 129. Champion Oncology Preclinical CRO Product
Table 130. Champion Oncology Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 131. Champion Oncology Recent Development
Table 132. Xentech Company Details
Table 133. Xentech Business Overview
Table 134. Xentech Preclinical CRO Product
Table 135. Xentech Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 136. Xentech Recent Development
Table 137. Living Tumor Laboratory Company Details
Table 138. Living Tumor Laboratory Business Overview
Table 139. Living Tumor Laboratory Preclinical CRO Product
Table 140. Living Tumor Laboratory Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 141. Living Tumor Laboratory Recent Development
Table 142. JOINN Lab Company Details
Table 143. JOINN Lab Business Overview
Table 144. JOINN Lab Preclinical CRO Product
Table 145. JOINN Lab Revenue in Preclinical CRO Business (2016-2021) & (US$ Million)
Table 146. JOINN Lab Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical CRO Market Share by Type: 2020 VS 2027
Figure 2. Security Evaluation Service Features
Figure 3. Pharmacokinetic Research Features
Figure 4. Pharmacodynamic Research Features
Figure 5. Other Features
Figure 6. Global Preclinical CRO Market Share by Application: 2020 VS 2027
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Biotechnology Case Studies
Figure 9. Preclinical CRO Report Years Considered
Figure 10. Global Preclinical CRO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Preclinical CRO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Preclinical CRO Market Share by Regions: 2020 VS 2027
Figure 13. Global Preclinical CRO Market Share by Regions (2022-2027)
Figure 14. Global Preclinical CRO Market Share by Players in 2020
Figure 15. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical CRO as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Preclinical CRO Revenue in 2020
Figure 17. Global Preclinical CRO Revenue Market Share by Type (2016-2021)
Figure 18. Global Preclinical CRO Revenue Market Share by Type (2022-2027)
Figure 19. North America Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Preclinical CRO Market Share by Type (2016-2027)
Figure 21. North America Preclinical CRO Market Share by Application (2016-2027)
Figure 22. North America Preclinical CRO Market Share by Country (2016-2027)
Figure 23. United States Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Preclinical CRO Market Share by Type (2016-2027)
Figure 27. Europe Preclinical CRO Market Share by Application (2016-2027)
Figure 28. Europe Preclinical CRO Market Share by Country (2016-2027)
Figure 29. Germany Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Preclinical CRO Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Preclinical CRO Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Preclinical CRO Market Share by Region (2016-2027)
Figure 39. China Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Preclinical CRO Market Share by Type (2016-2027)
Figure 47. Latin America Preclinical CRO Market Share by Application (2016-2027)
Figure 48. Latin America Preclinical CRO Market Share by Country (2016-2027)
Figure 49. Mexico Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Preclinical CRO Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Preclinical CRO Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Preclinical CRO Market Share by Country (2016-2027)
Figure 55. Turkey Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Preclinical CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Charles River Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 59. Eurofins Scientific Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 60. Wuxi AppTec Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 61. Pharmaceutical Product Development (PPD), LLC Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 62. ICON Plc. Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 63. Labcorp Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 64. CRL Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 65. Crown Bioscience Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 66. Taconic Biosciences Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 67. Covance Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 68. EVOTEC Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 69. The Jackson Laboratory Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 70. MI Bioresearch Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 71. Champion Oncology Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 72. Xentech Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 73. Living Tumor Laboratory Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 74. JOINN Lab Revenue Growth Rate in Preclinical CRO Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed